4Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
5Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growthfactor, expression in gastric carcinoma. Cancer, 1996,77:858-863.
6Anan K,Morisaki T,Katano M,et al. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic factors in human breast cancer. Surgery,1996,119:333-339.
7Berger DP, Herbstritt L, Dengler WA, et al.Vascular endothelial growth factor (VEGF) mRNA expression in human models of different histologies. Ann Oncol, 1995, 6: 818-825.
8Yoshiji H, Kuriyama S, Hicklin DJ, et al. The vascular endothelial growth factor receptorKDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model. Hepatology, 2001,33 : 841-847.
9Fuyuhiko Akiyoshi,Michio Sata,Hiroshi Suzuki,Yasuyo Uchimura,Keiichi Mitsuyama,Katsuhiko Matsuo,Kyuichi Tanikawa. Serum Vascular Endothelial Growth Factor Levels in Various Liver Diseases[J] 1998,Digestive Diseases and Sciences(1):41～45
5Perrone G,Santini D,Vincenzi B,et al.COX-2 expression in DCIS:correlation with VEGF,HER-2/neu,prognostic molecular markers and clinicopathological features.Histopathology,2005,46:561-568.
6Ribatti D.The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis:a historical review.Br J Haematol,2005,128:303-309.
7Akiyoshi F,Sata M,Suzuki H,et al.Serum vascular endothelial growth factor levels in various liver diseases.Dig Dis Sci,1998,43:41-45.
8Kitamura Y,Ninomiya H.Smad expression of hepatic stellate cells in liver cirrhosis in vivo an d hepatic stellate cellline in vitro.Pathol Int,2003,53:18-26.
9Nagashio Y.Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice.Lab Invest,2004,84:1610-1618.
